NEM vs. JNJ

Last updated Jun 9, 2026

NEM (Newmont Corporation) and JNJ (Johnson & Johnson) are both stocks. NEM operates in Gold (Basic Materials), while JNJ operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, NEM returned 13.46%/yr vs 10.06%/yr for JNJ. At a 0.07 correlation, their price movements are largely independent.

Performance

NEM vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Newmont Corporation (NEM) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NEM achieves a -0.43% return, which is significantly lower than JNJ's 13.43% return. Over the past 10 years, NEM has outperformed JNJ with an annualized return of 13.46%, while JNJ has yielded a comparatively lower 10.06% annualized return.

NEM

• 1D: -0.72%
• 1M: -14.84%
• YTD: -0.43%
• 6M: 11.71%
• 1Y: 91.07%
• 3Y*: 36.63%
• 5Y*: 10.33%
• 10Y*: 13.46%

JNJ

• 1D: -0.26%
• 1M: 5.50%
• YTD: 13.43%
• 6M: 16.43%
• 1Y: 53.49%
• 3Y*: 16.56%
• 5Y*: 10.04%
• 10Y*: 10.06%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NEM vs. JNJ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NEM Newmont Corporation	-0.43%	172.82%	-7.83%	-8.76%	-20.77%	7.40%	40.28%	30.52%	-6.15%	10.91%
JNJ Johnson & Johnson	13.43%	47.48%	-4.81%	-8.58%	5.97%	11.44%	10.82%	16.22%	-5.13%	24.43%

Correlation

The correlation between NEM and JNJ is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.17
Correlation (10Y) Calculated over the trailing 10-year period	0.15
Correlation (All Time) Calculated using the full available price history since Apr 6, 1983	0.07

The correlation between NEM and JNJ shifts across timeframes, from 0.07 (all time) to 0.17 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS NEM : $6.34 JNJ : $8.65
PE Ratio NEM : 15.62 JNJ : 26.85
PEG Ratio NEM : 0.41 JNJ : 0.89
PS Ratio NEM : 4.77 JNJ : 5.86
Total Revenue (TTM) NEM : $17.23B JNJ : $96.36B
Gross Profit (TTM) NEM : $8.97B JNJ : $66.60B
EBITDA (TTM) NEM : $13.78B JNJ : $31.62B

Return for Risk

NEM vs. JNJ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEM

NEM Risk / Return Rank: 85
NEM Sharpe Ratio Rank: 88
NEM Sortino Ratio Rank: 80
NEM Omega Ratio Rank: 82
NEM Calmar Ratio Rank: 86
NEM Martin Ratio Rank: 86

JNJ

JNJ Risk / Return Rank: 95
JNJ Sharpe Ratio Rank: 96
JNJ Sortino Ratio Rank: 97
JNJ Omega Ratio Rank: 95
JNJ Calmar Ratio Rank: 92
JNJ Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NEM vs. JNJ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Newmont Corporation (NEM) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NEM	JNJ	Difference
Sharpe ratio: Return per unit of total volatility	1.96	3.19	-1.24
Sortino ratio: Return per unit of downside risk	2.26	4.65	-2.39
Omega ratio: Gain probability vs. loss probability	1.32	1.57	-0.25
Calmar ratio: Return relative to maximum drawdown	3.36	4.91	-1.55
Martin ratio: Return relative to average drawdown	8.94	14.52	-5.58
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NEM vs. JNJ - Sharpe Ratio Comparison

The current NEM Sharpe Ratio is 1.96, which is lower than the JNJ Sharpe Ratio of 3.19. The chart below compares the historical Sharpe Ratios of NEM and JNJ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NEM	JNJ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.96	3.19	-1.24
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.27	0.60	-0.32
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.55	-0.17
Sharpe Ratio (All Time) Calculated using the full available price history	0.12	0.54	-0.41

Drawdowns

NEM vs. JNJ - Drawdown Comparison

The maximum NEM drawdown since its inception was -81.30%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for NEM and JNJ.

Drawdown Indicators

	NEM	JNJ	Difference
Max Drawdown Largest peak-to-trough decline	-81.30%	-50.67%	-30.63%
Max Drawdown (1Y) Largest decline over 1 year	-27.25%	-10.96%	-16.29%
Max Drawdown (3Y) Largest decline over 3 years	-36.57%	-15.95%	-20.62%
Max Drawdown (5Y) Largest decline over 5 years	-62.40%	-18.41%	-43.99%
Max Drawdown (10Y) Largest decline over 10 years	-62.40%	-27.37%	-35.03%
Current Drawdown Current decline from peak	-24.65%	-6.06%	-18.59%
Average Drawdown Average peak-to-trough decline	-41.38%	-11.88%	-29.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.22%	3.70%	+6.52%

Volatility

NEM vs. JNJ - Volatility Comparison

Newmont Corporation (NEM) has a higher volatility of 14.19% compared to Johnson & Johnson (JNJ) at 5.80%. This indicates that NEM's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NEM	JNJ	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.19%	5.80%	+8.39%
Volatility (6M) Calculated over the trailing 6-month period	36.93%	12.41%	+24.52%
Volatility (1Y) Calculated over the trailing 1-year period	46.87%	16.87%	+30.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.83%	16.87%	+20.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.59%	18.47%	+17.12%

Dividends

NEM vs. JNJ - Dividend Comparison

NEM's dividend yield for the trailing twelve months is around 1.03%, less than JNJ's 2.26% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JNJ Johnson & Johnson	2.26%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%
NEM Newmont Corporation	1.03%	1.00%	2.69%	3.87%	4.66%	3.55%	1.74%	3.31%	1.62%	0.67%	0.37%	0.56%

Financials

Frequently Asked Questions

Can I hold both NEM and JNJ in my portfolio?

NEM and JNJ have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NEM or JNJ?

NEM has higher volatility (14.19%) compared to JNJ (5.80%). In terms of maximum drawdown, NEM dropped -81.30% vs JNJ's -50.67%.

Which has better risk-adjusted returns?

JNJ currently has the higher Sharpe Ratio (3.19 vs 1.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.